Industry Insight
Discovery Technology
Analytical Laboratory Technology
Biopharma
Manufacturing
Delivery Systems
Ingredients, Formulation and Finishing
Bioprocessing
View our other publications with free access to extensive archives
  To print this article:
Existing subscribers please log in:
 
  USER NAME  
  PASSWORD  
   Or select

Or become a subscriber
 
 
 

Injecting Potential

As commercial launches of wearable injectors begin, chronic disease patients could see their treatment being revolutionised. Michael Hooven of Enable Injections discusses how these new devices can reduce healthcare costs and boost patient quality of life.

Michael Hooven (September 2015)

Keywords: Injection systems, Biologics, Human factors engineering, Needlestick injury

    View full article    |    Back to Delivery systems section




Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPTonline © 2004 The Pharmaceutical Technology Journal | Terms and Conditions | info@iptonline.com | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |